Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis

Fertility and Sterility

Volumn 92, Issue 4, 2009, Pages 1234-1239

  Tokushige, Natsuko ^a   Markham, Robert ^a   Russell, Peter ^a   Fraser, Ian S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Endometriosis; hormone therapy; nerve fibers; peritoneal endometriotic lesions

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PROTEIN P75;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CURETTAGE; DRUG MECHANISM; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTEROSCOPY; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; NERVE FIBER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; BIOPSY; CASE-CONTROL STUDIES; CELL COUNT; CONTRACEPTIVES, ORAL, COMBINED; ENDOMETRIOSIS; FEMALE; HUMANS; MIDDLE AGED; NERVE FIBERS; NERVE GROWTH FACTOR; PERITONEAL DISEASES; PROGESTINS; RECEPTOR, NERVE GROWTH FACTOR; UBIQUITIN THIOLESTERASE; YOUNG ADULT;

EID: 70349464862     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.07.1774     Document Type: Article

References (31)

1. Rice V.M. Conventional medical therapies for endometriosis. Ann NY Acad Sci 955 (2002) 343-352
2. Meresman G.F., Augé L., Barańao R.I., Lombardi E., Tesone M., and Sueldo C. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril 77 (2002) 1141-1147
3. Luciano A.A., Turksoy R.N., and Carleo J. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. Obstet Gynecol 72 (1988) 323-327
4. Schweppe K.W. Current place of progestins in the treatment of endometriosis-related complaints. Gynecol Endocrinol 15 (2001) 22-28
5. Blei F., Wilson E.L., Mignatti P., and Rafkin D.B. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 155 (1993) 568-578
6. ESHRE Capri Workshop Group. Ovarian and endometrial function during hormonal contraception. Hum Reprod 16 (2001) 1527-1535
7. Vercellini P., Pietropaolo G., Giorgi O.D., Pasin P., Chiodini A., and Crosignani G. Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. Fertil Steril 84 (2005) 1375-1387
8. Tamburro S., Canis M., Albuisson E., Dechelotte P., Darcha C., and Mage G. Expression of transforming growth factor beta1 in nerve fibers is related to dysmenorrhea and laparoscopic appearance of endometriotic implants. Fertil Steril 80 (2003) 1131-1136
9. Tulandi T., Felemban A., and Chen M.F. Nerve fibers and histopathology of endometriosis-harboring peritoneum. J Am Assoc Gynecol Laparosc 8 (2001) 95-98
10. Tokushige N., Markham R., Russell P., and Fraser I.S. Nerve fibres in peritoneal endometriosis. Hum Reprod 21 (2006) 3001-3007
11. Berkley K.J., Dmitrieva N., Curtis K.S., and Papka R.E. Innervation of ectopic endometrium in a rat model of endometriosis. Proc Natl Acad Sci USA 101 (2004) 11094-11098
12. Tokushige N., Markham R., Russell P., and Fraser I.S. Effects of hormonal treatment on nerve fibers in endometrium and myometrium in women with endometriosis Fertil Steril. Published online (November 30, 2007)
13. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67 (1996) 817-821
14. Sharpe-Timms K.L. Endometrial anomalies in women with endometriosis. Ann NY Acad Sci 943 (2001) 131-147
15. Matsuzaki S., Canis M., Pouly J.L., Déchelotte P.J., and Mage G. Analysis of aromatase and 17β-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection. Fertil Steril 8 (2006) 308-313
16. Bukulmez O., Hardy D.B., Carr B.R., Word R.A., and Mendelson C.R. Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology 149 (2008) 1190-1204
17. Hudelist G., Czerwenka K., Keckstein J., Haas C., Fink-Retter A., Gschwantler-Kaulich D., et al. Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis. Reprod Sci 14 (2007) 798-805
18. Zeitoun K., Takayama K., Sasano H., Suzuki T., Moghrabi N., Andersson S., et al. Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17β-estradiol. J Clin Endocrinol Metab 83 (1998) 4474-4480
19. Dassen H., Punyadeera C., Kamps R., Delvoux B., Van Langendonckt A., Donnez J., et al. Estrogen metabolizing enzymes in endometrium and endometriosis. Hum Reprod 22 (2007) 3148-3158
20. Kousteni S., Bellido T., Plotkin L., O'Brien C., Bodenner D., Han L., et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104 (2001) 719-730
21. Jones R.K., Searle R.F., and Bulmer J.N. Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis. Hum Reprod 13 (1998) 3496-3502
22. Bjorling D.E., Beckman M., Clayton M.K., and Wang Z.Y. Modulation of nerve growth factor in peripheral organs by estrogen and progesterone. Neuroscience 110 (2002) 155-167
23. Krizsan-Agbas D., Pedchenko T., Hasan W., and Smith P.G. Estrogen regulates sympathetic neurite outgrowth by modulating brain derived neurotrophic factor synthesis and release by the rodent uterus. Eur J Neurosci 18 (2003) 2760-2768
24. Danilkovitch A., Donley S., Skeel A., and Leonard E.J. Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells. Mol Cell Biol 20 (2000) 2218-2227
25. Matsuzaki S., Canis M., Pouly J.L., Déchelotte P., Okamura K., and Mage G. The macrophage stimulating protein/RON system: a potential novel target for prevention and treatment of endometriosis. Mol Hum Reprod 11 (2005) 345-349
26. Chen D.F., Schneider G.E., Martinou J.C., and Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385 (1997) 434-439
27. Clark R.S., Chen J., Watkins S.C., Kochanek P.M., Chen M., Stetler R.A., et al. Apoptosis-suppressor gene bcl-2 expression after traumatic brain injury in rats. J Neurosci 17 (1997) 9172-9182
28. Béliard A., Noël A., and Foidart J.M. Reduction of apoptosis and proliferation in endometriosis. Fertil Steril 82 (2004) 80-85
29. Watanabe H., Kanzaki H., Narukawa S., Inoue T., Katsuragawa H., Kaneko Y., and Mori T. Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis. Am J Obstet Gynecol 176 (1997) 360-368
30. Metzger D.A., Olive D.L., and Haney A.F. Limited hormonal responsiveness of ectopic endometrium: histologic correlation with intrauterine endometrium. Hum Pathol 19 (1988) 1417-1424
31. Vierikko P., Kauppila A., Rönnberg L., and Vihko R. Steroidal regulation of endometriosis tissue: lack of induction of 17β-hydroxysteroid dehydrogenase activity by progesterone, medroxyprogesterone acetate, or danazol. Fertil Steril 43 (1985) 218-224